-transparent.png){kind=logo}
1. The bioavailabilities of carbamazepine in 100 mg and 200 mg tablets have been compared in a cross-over study of six subjects after two 600 mg doses of the drug, the different preparations being taken at 3 week intervals. 2. Areas under the plasma level curves, absorption rate constants and times to achieve peak plasma levels showed little difference between the two preparations. These findings suggest similar rates and extents of bioavailability of carbamazepine in the two preparations. 3. Calculated mean absorption and elimination parameters for carbamazepine were as follows: kabs = 0.1081 h-1, (s.d. = 0.0289); Tmax = 23.39 h, (s.d. = 8.66); k = 0.0191 h-1, (s.d. = 0.0033); VD = 0.989 1/kg, (s.d. = 0.159); and clearance = 0.0185 1/kg h, (s.d. = 0.0015).
G A Smith, and
W D Hooper, and
J H Tyrer, and
M J Eadie, and
B Werth
January 1984,
The Journal of international medical research,
G A Smith, and
W D Hooper, and
J H Tyrer, and
M J Eadie, and
B Werth
August 1993,
East African medical journal,
G A Smith, and
W D Hooper, and
J H Tyrer, and
M J Eadie, and
B Werth
December 1983,
International journal of clinical pharmacology, therapy, and toxicology,
G A Smith, and
W D Hooper, and
J H Tyrer, and
M J Eadie, and
B Werth
September 1999,
The Journal of the Association of Physicians of India,
G A Smith, and
W D Hooper, and
J H Tyrer, and
M J Eadie, and
B Werth
July 1979,
European journal of clinical pharmacology,
G A Smith, and
W D Hooper, and
J H Tyrer, and
M J Eadie, and
B Werth
January 2005,
Biopharmaceutics & drug disposition,
G A Smith, and
W D Hooper, and
J H Tyrer, and
M J Eadie, and
B Werth
August 2016,
Epilepsia,
G A Smith, and
W D Hooper, and
J H Tyrer, and
M J Eadie, and
B Werth
January 1987,
Therapeutic drug monitoring,
G A Smith, and
W D Hooper, and
J H Tyrer, and
M J Eadie, and
B Werth
November 2010,
Drug design, development and therapy,
G A Smith, and
W D Hooper, and
J H Tyrer, and
M J Eadie, and
B Werth
July 2005,
International journal of clinical pharmacology and therapeutics,
